Literature DB >> 25971761

Breaking down barriers to initiating insulin: Insulin prescription pad.

Alia Ali1, Alice Y Y Cheng2, Catherine H Yu3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25971761      PMCID: PMC4430062     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  8 in total

Review 1.  Initiating insulin in patients with type 2 diabetes.

Authors:  Adrian N C Lau; Terence Tang; Henry Halapy; Kevin Thorpe; Catherine H Y Yu
Journal:  CMAJ       Date:  2012-04-02       Impact factor: 8.262

2.  Pharmacologic management of type 2 diabetes.

Authors:  William Harper; Maureen Clement; Ronald Goldenberg; Amir Hanna; Andrea Main; Ravi Retnakaran; Diana Sherifali; Vincent Woo; Jean-François Yale
Journal:  Can J Diabetes       Date:  2013-03-26       Impact factor: 4.190

3.  Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study.

Authors:  Mark Peyrot; Richard R Rubin; Torsten Lauritzen; Soren E Skovlund; Frank J Snoek; David R Matthews; Rüdiger Landgraf; Line Kleinebreil
Journal:  Diabetes Care       Date:  2005-11       Impact factor: 19.112

4.  Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Introduction.

Authors:  Alice Y Y Cheng
Journal:  Can J Diabetes       Date:  2013-03-26       Impact factor: 4.190

5.  United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group.

Authors: 
Journal:  Ann Intern Med       Date:  1998-02-01       Impact factor: 25.391

6.  A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies with Insulin Glargine for Hyperglycaemia Treatment) Study.

Authors:  H C Gerstein; J-F Yale; S B Harris; M Issa; J A Stewart; E Dempsey
Journal:  Diabet Med       Date:  2006-07       Impact factor: 4.359

Review 7.  Insulin delivery systems: reducing barriers to insulin therapy and advancing diabetes mellitus treatment.

Authors:  Stephen Brunton
Journal:  Am J Med       Date:  2008-06       Impact factor: 4.965

8.  Transition to insulin in Type 2 diabetes: family physicians' misconception of patients' fears contributes to existing barriers.

Authors:  Sasson Nakar; Gila Yitzhaki; Reena Rosenberg; Shlomo Vinker
Journal:  J Diabetes Complications       Date:  2007 Jul-Aug       Impact factor: 2.852

  8 in total
  2 in total

1.  Hypoglycemia in type 2 diabetes: It is common, so what strategies can minimize the risk?

Authors:  Marlys LeBras; Tessa Laubscher
Journal:  Can Fam Physician       Date:  2021-01       Impact factor: 3.275

2.  GOAL study: clinical and non-clinical predictive factors for achieving glycemic control in people with type 2 diabetes in real clinical practice.

Authors:  Abdulqawi Al Mansari; Youssef Obeid; Najmul Islam; Mohammed Fariduddin; Ahmed Hassoun; Khier Djaballah; Mojtaba Malek; Dror Dicker; Tirthankar Chaudhury
Journal:  BMJ Open Diabetes Res Care       Date:  2018-07-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.